Involvement of capsaicin-sensitive nerves in the regulation of glucose tolerance in diabetic rats

Life Sciences

Volumn 59, Issue 12, 1996, Pages 969-977

  Guillot, E ^a   Coste, A ^a   Angel, I ^a  

^a SANOFI   (France)

Author keywords

Adrenergic alpha2 receptor; Afferent pathways; Diabetes; Glucose tolerance test; Insulin

Indexed keywords

1,2,4,5 TETRAHYDRO 2 (2 IMIDAZOLIN 2 YL) 2 PROPYLPYRROLO[3,2,1 HI]INDOLE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CAPSAICIN; DERIGLIDOLE; GLUCOSE; INSULIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; NEWBORN; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RAT; REGULATORY MECHANISM; SENSORY NERVE; STREPTOZOCIN DIABETES;

EID: 0030590242     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00403-1     Document Type: Article

References (29)

1. 1. J.H. STRUBBE, Neth. J. Med. 34 154-167 (1989).
2. 2. M. PETTERSSON, B. AHRÈN, G. BÖTTCHER and F. SUNDLER, Endocrinology 119 865-869 (1986).
3. 3. S. BEVAN and J. SZOLCSÁNYI, Trends Pharmacol. Sci. 11 330-333 (1990).
4. 4. J. I. NAGY, S. P. HUNT, L.L. IVERSON and P. C. EMSON, Neuroscience 6 1923-1934 (1981).
5. 5. S. KARLSSON, F. SUNDLER and B. AHRÈN, J. Auton. Nerv. Syst. 32 51-60 (1992).
6. 6. S. KARLSSON , A. J. W. SCHEURINK, A. B. STEFFENS and B. AHRÉN, Am. J. Physiol. 267 R1071-R1077 (1994).
7. 7. X-F. ZHOU, K.H. JHAMANDAS and B.G. LIVETT, Am. J. Physiol. 258 E212-E219 (1990).
8. 8. M-H. GIROIX , A. SENER, D. BAILBE, V. LECLERCQ-MEYER, B. PORTHA and W. J. MALAISSE, Biochem. Med. Metab. Biol. 50 301-321 (1993).
9. 9. F. LEFEVRE-BORG, M-T EON, M. PROUTEAU, S. ARBILLA and I. ANGEL, Diabetologia 35 suppl 1 A79 (1992).
10. 10. P. HOLZER, Pharmacol. Rev. 43 143-201 (1991).
11. 11. S. BONNER-WEIR, D. F. TRENT, R. N. HONEY and G. C. WEIR, Diabetes 30 64-69 (1981).
12. 12. G. C. WEIR, E. T. CLORE, C. J. ZMACHINSKI and S. BONNER-WEIR, Diabetes 30 590-595 (1981).
13. 13. M-H. GIROIX, B. PORTHA, M. KERGOAT, D. BAILBE and L. PICON, Diabetes 32 445-451 (1983).
14. 14. S. A. METZ, J. B. HALTER and R. P. ROBERTSON, Diabetes 27 554-562 (1978).
15. 15. M. W. ROY, K. C. LEE, M. S. JONES and R. E. MILLER, Endocrinology 115 770-775 (1984).
16. 16. I. ANGEL, S. BIDET and S. Z. LANGER, J. Pharmacol. Exp. Ther. 246 1098-1103 (1988).
17. 17. I. ANGEL and S. Z. LANGER, Eur. J. Pharmacol. 154 191-196 (1988).
18. 18. I. ANGEL, R. NIDDAM and S. Z. LANGER, J. Pharmacol. Exp. Ther. 254 877-882 (1990).
19. 19. J-C. JONAS, T. D. PLANT, I. ANGEL, S. Z. LANGER and J. C. HENQUIN, Eur. J. Pharmacol. 254 27-33 (1994).
20. 20. M. TAOUIS, M. BERLAN, P. MONTASTRUC, M. LAFONTAN, J. Pharmacol. Exp. Ther. 247 1172-1180 (1988).
21. 21. H. BACHELARD, S. M. GARDINER, P. A. KEMP, T. BENNETT, Br. J. Pharmacol. 105 202-210 (1992).
22. 22. C. J. BAILEY, C. DAY, G. A. BRAY, L. G. LIPSON and P. R. FLATT, Horm. Metabol. Res. 18 357-360 (1986).
23. 23. E. GUILLOT, A. COSTE and I. ANGEL, Diabetologia 37 suppl 1 A150 (1994).
24. 24. M. SAITO and G. A. BRAY, Am. J. Physiol. 246 R20-R25 (1984).
25. 25. S. LENZEN and C. BAILEY, Endocr. Rev. 5 411-434 (1984).
26. 26. A. EKSTRAND, C. SALORANTA , J. AHONEN, C. GRONHAGEN-RISKA and LC. GROOP, Metabolism. 41 692-697 (1992).
27. 27. J. DONNERER and F. LEMBECK, Br. J. Pharmacol. 94 647-652 (1988).
28. 28. J. DONNERER, R. AMANN, G. SKOFITSCH and F. LEMBECK, Ann. N. Y. Acad. Sci. 632 296-303 (1991).
29. 29. V. COIRO, L. CAPRETTI, R. VOLPI, C. DAVOLI, A. MARCATO, U. CAVAZZINI, G. CAFFARRI, G. ROSSI and P. CHIODERA, Neuroendocrinology 56 459-463 (1992).